New Guidelines Regarding Active Surveillance of Low Risk Prostate Cancer

Active Surveillance is becoming more recognized as a reasonable alternative to immediate therapy for localized prostate cancer, particularly men with low risk disease (PSA less than 10 ng/ml, Gleason 3+3, normal rectal exam). A recent guideline by the National Cancer Cooperative Network has gone as far as now recommending active surveillance as the right treatment for all men with very low risk disease. This video explores that recommendation and whether it is fully justified.